Regulatory efficiency is essential in the current fast paced pharmaceutical landscape. Global Electronic Submissions have transformed the way companies have been presenting their drug applications and data to health authorities all over the world. This digital transformation, which replaces paper processes, also increases drug approval times, supports compliance, and facilitates the delivery of life-saving medications… Continue reading What is Global Electronic Submissions
Author: masuuglobal
What is an Standard Operating Procedure (SOP)
In any successful business—especially in industries like pharmaceuticals, biotechnology, manufacturing, logistics, and food processing—consistency and compliance are key. One of the most effective tools to ensure both is the use of SOPs, or Standard Operating Procedure. At Masuu global, we assist organizations to develop and implement effective SOPs that can enhance their operations and orient… Continue reading What is an Standard Operating Procedure (SOP)
What is a DUNS Number and Why Does Your Business Need One?
What is a DUNS Number and Why Does Your Business Need One? Credibility and transparency are the secrets of success in the contemporary business environment that is characterized by global interconnectedness. Among the key instruments that contribute to the creation of both is a DUNS Number. In Masuu Global, we have realized the significance that… Continue reading What is a DUNS Number and Why Does Your Business Need One?
Nitrosamine Impurity Risk Assessment: Ensuring Product Safety and Regulatory Compliance
Nitrosamine Impurity Risk Assessment: Ensuring Product Safety and Regulatory Compliance The use of nitrosamines in pharmaceutical manufacturing has become a major topic of interest because it is considered a probable carcinogen in humans. All regulators, such as the FDA and EMA, are currently mandating manufacturers to evaluate and mitigate the risk of nitrosamine impurities in… Continue reading Nitrosamine Impurity Risk Assessment: Ensuring Product Safety and Regulatory Compliance
What is an Investigational Medicinal Product Dossier (IMPD)
What is an Investigational Medicinal Product Dossier (IMPD)? A Guide to the Investigational Medicinal Product Dossier Regulatory documentation is crucial in ensuring safety and effectiveness of the new medicines in the complicated world of drug development and clinical research. The IMPD, or the Investigational Medicinal Product Dossier is one of those key documents in the… Continue reading What is an Investigational Medicinal Product Dossier (IMPD)
What is a Pharmacovigilance System Master File (PSMF)?
Pharmaceutical industries require their products to be able to promote drug safety during the lifecycle of such products. The Pharmacovigilance System Master File (PSMF) is one of the most important documents in favor of this endeavor in the European Union (EU) and other areas. So, what is a PSMF and why is this so essential… Continue reading What is a Pharmacovigilance System Master File (PSMF)?
What is an Active Substance Master File (ASMF) Submission
What is an Active Substance Master File (ASMF) Submission and Why It Matters in Pharmaceutical Regulatory Strategy The pharmaceutical industry is a highly regulated sector where the quality, safety and efficacy of a drug product is highly reliant on the quality of its components-most predominantly the active pharmaceutical ingredient (API). The Active Substance Master File… Continue reading What is an Active Substance Master File (ASMF) Submission
What is New Drug Application (NDA) Submission
New Drug Application (NDA) Submission: Your Path to U.S. Market Approval Marketing a product through pharmaceutical science is a major scientific and regulatory accomplishment. The NDA is the regulated pathway by which small-molecule drug developers can endeavor to obtain the authorization to market their products (via marketing approval by the United States FDA). We at… Continue reading What is New Drug Application (NDA) Submission
What is an Investigational New Drug (IND) Application
Investigational New Drug (IND) Application: Laying the Foundation for Clinical Trials Before a new drug can be tested in people in the USA, it must first get approval from the U.S. Food and Drug Administration (FDA) through an Investigational New Drug (IND) application. At Masuu Global, we guide sponsors through this essential regulatory gateway—giving you… Continue reading What is an Investigational New Drug (IND) Application
What is 21 CFR Part 11
What is 21 CFR Part 11? In our digital era, FDA-regulated industries are supposed to be confident that their e-records and signatures are no less reliable than paper ones. It is here that 21 CFR Part 11 is used. It is an essential regulation developed by the U.S Food and Drug Administration (FDA) that establishes… Continue reading What is 21 CFR Part 11
